普雷尼索隆与环素作为Kawasaki病的初始治疗方法
Satoko Kameda1, Yusuke Sasabuchi1,2, Nobuaki Michihata3
1Data Science Center, Jichi Medical University, Shimotsuke, Japan.
概括
普雷迪尼索隆和环素在预防川崎病冠状动脉异常方面提供了类似的结果. 然而,环素导致医院住院时间较短,相比普雷迪尼索隆.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 川崎病是儿童获得心脏病的主要原因.
- 静脉注射免疫球蛋白 (IVIG) 是标准的治疗方法,但预防冠状动脉异常 (CAA) 仍然是一个挑战.
- 普雷迪尼索隆和环素与IVIG结合使用,但它们的比较有效性尚不清楚.
研究的目的:
- 为了比较卡瓦萨基病初始组合治疗的临床结果,使用普雷迪尼索隆与环素.
- 评估这些治疗方法在预防冠状动脉异常 (CAA) 方面的疗效.
主要方法:
- 使用日本诊断程序组合数据库进行回顾性队列研究 (2014年4月 - 2021年3月).
- 已确定患有川崎病的患者接受IVIG加上普雷迪尼索隆或环素治疗.
- 倾向性得分匹配用于比较结果,包括CAA,IVIG耐药性,医疗费用和住院时间.
主要成果:
- 总共有6288名患者被分析 (6147人接受了普雷迪尼索隆,141人接受了环素).
- 在前列尼索隆和环素组之间,在CAA,IVIG耐药性或医疗费用的比例上没有发现显著差异.
- 在普得尼索隆组 (14天) 的住院时间与环素组 (11天) 相比,在普得尼索隆组 (14天) 的住院时间明显长.
结论:
- 普雷迪尼索隆和环素,当用于卡瓦萨基病的IVIG初始组合治疗时,在预防CAA方面表现出相似的有效性.
- 与普得尼索隆相比,环素可能与较短的住院时间有关.
- 根据这些发现,进一步的研究可能会探索川崎病的最佳治疗策略.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
141
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
141
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
281
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
281
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
154
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
154
01:29Inflammatory Bowel Disease IV: Pharmacological Management
137
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
137
01:26COPD: Management Using Bronchodilators and Corticosteroids
224
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
224